Adeel Khan, M.D.

Adeel Khan, M.D.

Director of Myeloma Epidemiology Research | Clinical Director of Monoclonal Gammopathy Precursor Clinic

  • Internal Medicine - Hematology/Oncology
  • Myeloma Treatment
  • Waldenström Macroglobulinemia


Adeel Khan, M.D., M.P.H., M.S., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He is also an Assistant Professor in the Peter O’Donnell Jr. School of Public Health. He specializes in myeloma, amyloidosis, and Waldenström macroglobulinemia and serves as the Director of Myeloma Epidemiology Research and Clinical Director of the Monoclonal Gammopathy Precursor Clinic.

Dr. Khan earned his medical degree with special distinction at the University of Michigan in Ann Arbor, Michigan, while also obtaining a master’s degree in public health from Harvard University. He performed a residency in internal medicine at the Cleveland Clinic and Lerner College of Medicine in Cleveland, Ohio. After serving as a hospitalist at Massachusetts General Hospital and an instructor at Harvard Medical School and concurrently obtaining a master's degree in epidemiology from Columbia University, he gained advanced training in hematology and oncology through a fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School.

Board certified in internal medicine and hematology, he joined the UT Southwestern faculty in 2022.

Dr. Khan’s research interests include myeloma and other monoclonal gammopathies, as well as cancer epidemiology. He has delivered numerous presentations at large national conferences and published peer-reviewed articles related to his areas of expertise.

He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, and the American Public Health Association.

Education & Training
  • Graduate School - Harvard T.H. Chan School of Public Health (2012-2013), Quantitative Methods
  • Graduate School - Columbia University Mailman School of Public Health (2017-2019), Epidemiology
  • Medical School - University of Michigan Medical School (2008-2014)
  • Residency - Cleveland Clinic Foundation (2014-2017), Internal Medicine
  • Fellowship - Beth Israel Deaconess Medical Center (2019-2022), Hematology Oncology
Professional Associations & Affiliations
  • American College of Physicians
  • American Public Health Association
  • American Society of Clinical Oncology
  • American Society of Hematology
Honors & Awards
  • Excellence in Teaching 2017, Cleveland Clinic
  • James H. Ware Award for Achievement in the Practice of Public Health 2013, Harvard University
  • Trong D. Nguyen Memorial Award 2013, American Public Health Association
  • Making a Difference Award 2011, University of Michigan
  • Phi Beta Kappa 2007, University of Oklahoma
Books & Publications
  • Cancer epidemiology
  • Clinical trials in hematologic malignancies
  • Health outcomes and disparities
  • Myeloma and other plasma cell dyscrasias

Clinical Focus

  • Myeloma Treatment
  • Waldenström Macroglobulinemia
  • Amyloidosis
  • General Hematology/Oncology
  • Cancer Epidemiology

See More